Introduction to the PNS: Adrenergic therapeutics Flashcards
1) which amino acid is noradrenaline synthesised from?
2) where is noradrenaline released from?
1) tyrosine via dopamine which is a precursor
2) released by post-ganglionic sympathetic nerves
- (noradrenaline -> adrenaline: hormone secreted by adrenal gland)
all postganglionic sympathetic fibres release noradrenaline. which receptors does noradrenaline act on?
act either on α or β-adrenoceptors
list the different Adrenoceptor subtypes and their locations
1) α1: smooth muscle
2) α2:smooth muscle
3) β1: heart
- increase cardiac rate and force
4) β2:smooth muscle heart
- Vasodilation, Bronchodilation
5) β3: skeletal muscle,fat
for each of the Adrenoceptor subtypes state the G-protein they are coupled to and the response
1) α1: Gαq - Increase in IP3
2) α2:Gαi/o- decrease in cAMP
3) β1-3: Gαs: increase in cAMP
outline the cardiovascular effects of Noradrenaline, Isoprenaline and Adrenaline
1) Noradrenaline:α-selective: causes vasoconstriction (α1), this causes reflex bradycardia (baroreceptor response) due to ACh action at vagal nerve. Overall increase in arterial (blood) pressure
2) Isoprenaline:β-selective: causes vasodilation (β2); tachycardia (β1). Overall decrease in BP
3) Adrenaline: β > α : intermediate action, low concentration ~ ISO; higher conc. ~ NA
outline the difference between a cholinergic and a Adrenergic synapse
1) Adrenergic- no acetylcholinesterase instead there is a uptake 1’ transport system which can remove adrenaline
2) Tyrosine hydroxylase only found in noradrenergic neurones
how is noradrenaline regulated in Adrenergic transmission?
1) noradrenaline regulates its own release by feeding back on α2 receptors ( negative feedback loop)
2) the body regulates noradrenaline by using the uptake 1 and uptake 2 system
outline the therapeutic uses of adrenoceptor agonists on the following:
1) cardiovascular
2) respiratory
3) Urinary
1) Cardiovascular:
- Cardiac arrest: adrenaline IV
- Cardiogenic shock: β1-selective adrenoceptor agonist dobutamine acts to increase cardiac output
2) Respiratory: Asthma: β2-selective agonists salbutamol, terbutaline (short-acting) are inhalation bronchodilators; salmeterol, formoterol (long-lasting) used for chronic, nocturnal but not acute, attacks.
3) Urinary: Overactive bladder (incontinence): β3-selective agonist mirabegron
outline the therapeutic uses of adrenoceptor agonists on the following:
1) Anaphylaxis
2) Local anaesthesia
1) Anaphylaxis: Adrenaline (EpiPen®) is life-saving in acute hypersensitivity; acts to cause bronchodilation (via β2 adrenorecptor) and to raise blood pressure (via α1 adrenoceptor)
2) Local anaesthesia: Adrenaline is used to prolong LA action e.g. lidocaine in dental procedures, bupivacaine in spinal anaesthesia
What are the effects of histamine release as a result of Anaphylaxis on the body?
1) bronchoconstriction
2) vasodilation
3) inflammation
outline the therapeutic uses of adrenoceptor agonists on the following:
1) Glaucoma
2) LabouR
1) Glaucoma: Adrenaline or brimonidine, apraclonidine (both selective α2-agonists) can be used to reduce intra-ocular pressure in patients
2) Labour: β2-selective agonists ritodrine or salbutamol act as a smooth muscle relaxant to inhibit sympathetic-induced contraction of the pregnant uterus to prevent premature labour at 24 - 33 weeks gestation
Outline the therapeutics uses of α-adrenoceptor antagonists on the following:
1) Hypertension
2) Benign prostatic hyperplasia
1) Hypertension: Doxazosin or terazosin act on α1 adrenoceptors to cause vasodilation and decrease arterial blood pressure
2) Benign prostatic hyperplasia: α1A-adrenoceptor selective antagonists alfuzosin, indoramin or tamsulosin relaxes smooth muscle in bladder and prostate to treat enlargement and urinary retention.
Outline the therapeutic uses of β-adrenoceptor antagonists on the following:
1) Cardiovascular
2) Glaucoma
3) migraine
(important)
1) Cardiovascular: The β-blockers propranolol, timolol (non-selective), metoprolol, atenolol (β1-selective) and acebutolol, pindolol (partial agonists) are important drugs in the treatment of angina, myocardial infarct, dysrhythmia, heart failure and hypertension
2) Glaucoma: Topical β-blocker commonly the drug of first choice: betaxolol , carteolol or timolol eye drops used; act to reduce production of aqueous humor and thus reduce intraocular pressure
3) Migraine: Propranolol or metaprolol use in migraine prophylaxis
summarise the Side-effects of β-adrenoceptor antagonists
1) Even ‘cardioselective’ β-blockers contraindicated in patients with asthma or obstructive airways disease (e.g. bronchitis, emphysema)
2) Dangerous cardiac depression/bradycardia
3) Eye drops used for glaucoma are contraindicated in patients with cardiovascular disease.
4) β2 receptors control glucose release from liver; contraindicated in patients prone to hypoglycaemia
5) Fatigue: β-blockers can cause tiredness
6) Cold extremities (due to reduced blood flow)
Why are there so many side-effects with cholinergic and adrenergic drugs?
The autonomic and somatic nervous systems are fundamental to human life (for homeostasis); any therapeutic intervention will thus have important effects